Changes in insulin secretion & clearance predict progression in stage 2 type 1 diabetes & response to teplizumab. Oral-minimal model identifies disease heterogeneity in stage 2 #T1D link.springer.com/article/10.1... ๐ #TrialNet #T1Dprevention
6
2
0
1